News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Chambers Michael Andrew
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/15/2023 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 5,947 shares
@ $109.19, valued at
$649.4k
Bought 4,032 shares
@ $109.89, valued at
$443.1k
|
|
| 08/14/2023 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 23,686 shares
@ $108.05, valued at
$2.6M
|
|
| 08/11/2023 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 2,206 shares
@ $104.67, valued at
$230.9k
Bought 1,091 shares
@ $105.9, valued at
$115.5k
Bought 31,570 shares
@ $106.26, valued at
$3.4M
|
|
| 03/08/2023 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 1,523 shares
@ $0
Granted 3,257 options to buy
@ $155.99, valued at
$508.1k
|
|
| 09/15/2022 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 20,744 shares
@ $103.87, valued at
$2.2M
Bought 30,106 shares
@ $104.67, valued at
$3.2M
Bought 6,250 shares
@ $105.16, valued at
$657.3k
|
|
| 09/14/2022 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted options to buy
@ $141.97, valued at
$0 |
|
| 08/22/2022 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Bought 40,110 shares
@ $108.2, valued at
$4.3M
Bought 6,060 shares
@ $108.8, valued at
$659.3k
|
|
| 06/06/2022 |
4
| Chambers Michael Andrew (Director) has filed a Form 4 on Sarepta Therapeutics, Inc.|
Txns:
| Granted 4,908 shares
@ $0
Granted 8,329 options to buy
@ $72.58, valued at
$604.5k
|
|
|
|